Skip to Content

Zevalin

In the US, Zevalin (ibritumomab systemic) is a member of the following drug classes: CD20 monoclonal antibodies, radiologic conjugating agents and is used to treat Non-Hodgkin's Lymphoma.

US matches:

Ingredient matches for Zevalin

Ibritumomab

Ibritumomab Tiuxetan is reported as an ingredient of Zevalin in the following countries:

  • Austria
  • Belgium
  • Canada
  • Croatia (Hrvatska)
  • Germany
  • Hong Kong
  • Hungary
  • Israel
  • Italy
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • South Africa
  • Spain
  • Switzerland
  • Turkey
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide